Literature DB >> 19957162

Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats.

Y F Li1, E Luo, G Feng, S S Zhu, J H Li, J Hu.   

Abstract

UNLABELLED: Systemic treatment with strontium ranelate (SR) was performed on ovariectomized (OVX) rats with fractured tibiae. Callus quality was assessed by radiographic, histological, micro-computerized tomography, and biomechanical examinations at 4 and 8 weeks after fracture. Results revealed that systemic applied SR promoted osteoporotic fracture healing.
INTRODUCTION: Several studies have demonstrated the dual effect of SR on osteoporotic and undisturbed bone. However, reports of their effect on osteoporotic fracture healing are limited. This study was designed to investigate the effects of SR on bone regeneration in OVX rats with fractured tibiae.
METHODS: Three months after being OVX, female Sprague-Dawley rats accepted bilateral osteotomy on proximal tibiae fixed with intramedullary wires and were divided into two groups: OVX and OVX + SR (625 mg/kg/day). Callus quality was evaluated at 4 and 8 weeks postfracture.
RESULTS: Compared with OVX group, SR treatment significantly increased bone formation, BMD, biomechanical strength, and improved microstructural properties of the callus. The ultimate load was increased by 211.0% and 61.4% (p<0.01), and the total bone volume of callus by 74.8% and 79.3% (p<0.01) at 4 and 8 weeks postfracture, respectively. SR treatment also promoted healing progress with increased osteogenesis at 4 weeks; more mature and tightly arranged woven or lamellar bone at 8 weeks across the fracture gap in histological analysis.
CONCLUSION: This study suggests that systemic treatment with strontium ranelate could promote tibial fracture healing in OVX rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19957162     DOI: 10.1007/s00198-009-1140-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  41 in total

1.  Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell.

Authors:  Monnipha Sila-Asna; Ahnond Bunyaratvej; Sakan Maeda; Hiromichi Kitaguchi; Narong Bunyaratavej
Journal:  Kobe J Med Sci       Date:  2007

2.  Osteoblasts play key roles in the mechanisms of action of strontium ranelate.

Authors:  T C Brennan; M S Rybchyn; W Green; S Atwa; A D Conigrave; R S Mason
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 3.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

4.  Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures.

Authors:  Per Aspenberg; Harry K Genant; Torsten Johansson; Antonio J Nino; Kyoungah See; Kelly Krohn; Pedro A García-Hernández; Christopher P Recknor; Thomas A Einhorn; Gail P Dalsky; Bruce H Mitlak; Anke Fierlinger; Mark C Lakshmanan
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

5.  Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants.

Authors:  S D Bain; C Jerome; V Shen; I Dupin-Roger; P Ammann
Journal:  Osteoporos Int       Date:  2008-12-19       Impact factor: 4.507

6.  Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model.

Authors:  Roseleen M McCann; Gary Colleary; Carolyn Geddis; Susan A Clarke; Grant R Jordan; Glenn R Dickson; David Marsh
Journal:  J Orthop Res       Date:  2008-03       Impact factor: 3.494

7.  Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor.

Authors:  Mathew Varkey; Cezary Kucharski; Michael R Doschak; Shelley R Winn; Elsa J Brochmann; Samuel Murray; John R Matyas; Ronald F Zernicke; Hasan Uludag
Journal:  Tissue Eng       Date:  2007-04

8.  Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.

Authors:  Louis C Gerstenfeld; Daniel J Sacks; Megan Pelis; Zachary D Mason; Dana T Graves; Mauricio Barrero; Michael S Ominsky; Paul J Kostenuik; Elise F Morgan; Thomas A Einhorn
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

9.  Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.

Authors:  Robert R Recker; Fernando Marin; Sophia Ish-Shalom; Rüdiger Möricke; Federico Hawkins; Georgios Kapetanos; María P de la Peña; Jörn Kekow; Jordi Farrerons; Beatriz Sanz; Heide Oertel; Jan Stepan
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

10.  Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.

Authors:  J Collette; O Bruyère; J M Kaufman; R Lorenc; D Felsenberg; T D Spector; M Diaz-Curiel; S Boonen; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

View more
  35 in total

1.  Strontium Ranelate and bone healing: report of two cases.

Authors:  Umberto Tarantino; Monica Celi; Luca Saturnino; Alessandro Scialdoni; Irene Cerocchi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-01

2.  Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits.

Authors:  En Luo; Jing Hu; Chongyun Bao; Yunfeng Li; Qisheng Tu; Dana Murray; Jake Chen
Journal:  Acta Biomater       Date:  2011-10-25       Impact factor: 8.947

3.  Strontium ranelate stimulates trabecular bone formation in a rat tibial bone defect healing process.

Authors:  C Lavet; G Mabilleau; D Chappard; R Rizzoli; P Ammann
Journal:  Osteoporos Int       Date:  2017-09-28       Impact factor: 4.507

4.  Possible benefits of strontium ranelate in complicated long bone fractures.

Authors:  Duarte Nuno Alegre; Costa Ribeiro; Carlos Sousa; João Correia; Luís Silva; Luís de Almeida
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 5.  How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.

Authors:  P J Marie; D Felsenberg; M L Brandi
Journal:  Osteoporos Int       Date:  2010-09-02       Impact factor: 4.507

Review 6.  Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.

Authors:  Emma D Deeks; Sohita Dhillon
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

7.  Strontium ranelate in fracture healing and joint pain improvement in a rheumatoid arthritis patient.

Authors:  Andy Li-Jen Liu; Po-Wen Shen; Perng-Jong Chen
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

Review 8.  [Medication and bone metabolism: Clinical importance for fracture treatment].

Authors:  F Barvencik
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

9.  Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

Authors:  Armando Luis Negri; Francisco Rodolfo Spivacow
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20

10.  Updates in biological therapies for knee injuries: bone.

Authors:  Mauricio Kfuri; Rafael Lara de Freitas; Bruno Bellaguarda Batista; Rodrigo Salim; Marcello Teixeira Castiglia; Ricardo Antonio Tavares; Paulo Henrique Araújo
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.